• Home
  • Technology
    • Big Data
    • IT Services
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • ERP
    • Robotics
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers to Know in 2022
    • 10 Best Innovative Companies to watch In 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Press Release
  • Privacy Policy
  • Terms & Conditions
Facebook Twitter Instagram LinkedIn
  • About Us
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
Facebook Twitter Instagram LinkedIn
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
  • Home
  • Technology
    • Big Data
    • IT Services
    • Storage
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • Robotics
    • ERP
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
    • Startup
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch in the World 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers in 2022
    • 10 Best Innovative Companies to watch in 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Featured Leaders
  • Press Release
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
Home»Latest News»Pfizer decides to cut-off the U.S. sales staff
Latest News

Pfizer decides to cut-off the U.S. sales staff

A Quick Glance:

  • Pfizer has decided to cut off the sales staff and build a workforce that increases its expertise.
  • Pfizer record $80 million in sales in 2021.
  • Pfizer will soon be launching the oral COVID-19 vaccine Paxlovid.

Pfizer, one of the biggest contributors as the COVID-19 vaccine provider, has announced that the company will be cutting off a few jobs from the sales department in the U.S. The company expects the doctors and healthcare providers to have fewer face-to-face interactions with the sales staff after the pandemic ends.

The decision stems from the recent discovery of record-breaking revenue sales in 2021. Amid COVID-19, Pfizer boosted the sale of the COVID-19 vaccine developed with Germany’s BioNTech SE. This led to record-breaking sales—for any pharmaceutical company— where Pfizer can expect over $80 million of revenue from 2021 sales.

Evolving as a Biopharma Company

The Chief Executive of Pfizer, Albert Bourla, stated that there will be some changes in the workforce at Pfizer as the company will ensure they have the right expertise and resources to meet the evolving needs.

Pfizer confirmed in a statement, “We are evolving into a more focused and innovative biopharma company, and evolving the way we engage with healthcare professionals in an increasingly digital world.”

Although, the statement did not hint at how many sales jobs will Pfizer cut off. It is speculated that the company will be eliminating a few hundred positions. Alongside, they will also be creating new positions in different areas for around half of those jobs.

As the world is going digital, they understands that their doctors and healthcare providers will be looking forward to half of the interactions with drug companies shifting to a virtual platform in the future.

New oral COVID-19 Vaccine

The projected sales in 2022 are surging higher and the analyst estimates it to be around $100 billion. Most of these sales are expected to be due to the COVID-19 vaccine Paxlovid, which will be launching in a new oral treatment. In the near end term, the vaccine and Paxlovid will be directly sold to the government.

Related Posts

The Best iOS 15 Features You Must Activate In Your Phone

August 1, 2022

When will Microsoft Launch its Xbox Cloud Gaming?

June 9, 2022

Twitter Might be Launching a Dedicated Spot for Podcasts

March 6, 2022

FCC to probe domestic Russian-owned media and telecom companies

March 6, 2022

Intel Upcoming Chips are 70 % faster for multithreaded performance

March 6, 2022

Elon Musk Pledges to Begin Starlink Services in Ukraine

March 1, 2022

Leave A Reply Cancel Reply

Stay In Touch
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
Recent

Award Pool: Empowering NFT World with Gamified Methodologies

May 1, 2022

EPI Group: A Leading Geoscience and Geophysical Consultancy

August 31, 2022

DynaQuest: Leveraging Technology for Better Future

December 18, 2022

Maisonette: Nurturing Parenting and Upgrading kids’ Lifestyle

November 10, 2022

Delft Circuits: Making Quantum Technologies A Reality

August 28, 2022

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

About Us

Corporate Leaders Magazine is one of the acclaimed monthly/quarterly business magazines in the country. We aim to cater to Business Owners and Entrepreneurship Enthusiasts of the country with disruptive entrepreneurship stories.

Facebook Twitter Instagram LinkedIn
Topics
  • Big Data
  • Cloud
  • IOT
  • Telecom
  • Tech News
Contact Info

5214F Diamond Hts Blvd Unit #1056, San Francisco, CA 94131, USA

Phone: +1(760)-284-3025

Email Us: info@corporateleadersmagazine.com

Latest Issue
dbf5675a-76a2-4eca-b687-4e19e37b64f2
Cover Featured (1) (1)
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
Copyright © 2023 Corporate Leaders Magazine LLC | All Rights Reserved